Systematic Review of Pharmacist-Led Interventions in Hematological Malignancies

A systematic review synthesizing evidence from 33 studies on pharmacist-led interventions for patients with hematological malignancies. The review, authored by Amna Mohamed and last updated in April 2026, qualitatively analyzes clinical, process-related, and economic outcomes across inpatient and outpatient settings. The findings are documented in a 16.6 KB DOCX file.

Use Cases

• Synthesizing evidence on medication management process improvements based on the review's findings for drug-related problems and care coordination.
• Analyzing heterogeneous clinical outcomes for disease response and survival based on the structured qualitative synthesis described.
• Evaluating preliminary economic outcomes and potential cost savings based on the limited economic evaluations included in the review.

Strengths

• The review is based on a defined set of 33 included studies, providing a structured evidence base.
• Analysis covers three distinct outcome domains: clinical (24 studies), process-related (23 studies), and economic (8 studies).
• The work is openly licensed under CC-BY-4.0, facilitating reuse and distribution.

Limitations

• Row count is unknown, which may limit suitability assessment for quantitative analysis.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small (16.6 KB), indicating limited raw data scope, likely containing only the review document.

Provenance

Source

figshare

Collection Method

Systematic review of published literature, following a protocol registered with PROSPERO (CRD420251147239).

Time Range

Temporal coverage of the included studies is not specified in the provided metadata.

Freshness

Last updated 2026-04-21 05:20:15; freshness should be verified.

Geography

Spatial coverage of the included studies is not specified in the provided metadata.